Skip to content

The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer

The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer - The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018350
Enrollment
500
Registered
2015-07-19
Start date
2015-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Surgery

Sponsors

Gastroenterological Surgery I, Hokkaido University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Histologically proven gastric carcinoma 2) MP,SS or deeper lesion without involvement of other organs, N0-2 excluding bulky N2 and M0 according to the Japanese classification system 3) tumor located in the upper, body and antrum of the stomach and indication for total or distal gastrectomy 4)No invasion to duodenum 5) Aged 20 to 80 year 6) PS (ECOG)0 or 1 7) Body mass index < 30 8) no history of gastrointestinal surgery 9) no history of chemotherapy or radiotherapy 10) Sufficient organ functions 11) provided written informed consent

Exclusion criteria

Exclusion criteria: 1)Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ. 2)Women during pregnancy or breast-feeding. 3)Severe mental disease. 4) Continuous systemic steroid therapy. 5)History of myocardial infarction or unstable angina pectoris within six months. 6)Uncontrollable hypertension. 7)Uncontrollable diabetes millutus or administration of insulin. 8)Severe respiratory disease requiring continuous oxygen therapy. 9)Severe adhesion. 10)Severe circulative disfunction. 11)No resection. 12)The person in charge judges as an inappropriate case.

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Achievemnt rate Background Procedure Operation time Blood loss Intraoperative complication Postoperative complication Postoperative chemotherapy

Countries

Japan

Contacts

Public ContactTadashi Yoshida

Hokkaido University Gastroenterological Surgery I

ta73825@dg7.so-net.ne.jp011-706-5927

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026